Literature DB >> 28181267

Longitudinal course of lung function in myotonic dystrophy type 1.

Catherine Thil1, Nelly Agrinier2, Bruno Chenuel1, Mathias Poussel1,3.   

Abstract

INTRODUCTION: Quality of life and prognosis among patients with myotonic dystrophy type 1 (DM1) depend on the degree of respiratory impairment. However, the changes over time in pulmonary function in DM1 have not been clearly described.
METHODS: We retrospectively reviewed pulmonary function tests of 80 DM1 patients followed for at least 5 years.
RESULTS: During 9.02 ± 3.4 years of follow-up, the average annual changes were: forced vital capacity (FVC) -0.034 ± 0.06 L (-0.72 ± 1.7% predicted); forced expiratory volume in 1 second (FEV1 ) -0.043 ± 0.05 L (-1.07 ± 1.7% predicted); and total lung capacity (TLC) -0.047 ± 0.1 L (-1.15 ± 1.7% predicted).
CONCLUSIONS: These results suggest that, compared with other neuromuscular disorders, DM1 is, overall, associated with slowly progressive impairment of lung function. Muscle Nerve 56: 816-818, 2017.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  hypercapnia; hypoxemia; lung function; lung restriction; myotonic dystrophy; neuromuscular disorder

Mesh:

Year:  2017        PMID: 28181267     DOI: 10.1002/mus.25604

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  4 in total

1.  Predictors of prognosis in type 1 myotonic dystrophy (DM1): longitudinal 18-years experience from a single center.

Authors:  Marco Mazzoli; Alessandra Ariatti; Gian Carlo Garuti; Virginia Agnoletto; Maurilio Genovese; Manuela Gozzi; Shaniko Kaleci; Alessandro Marchioni; Marcella Malagoli; Giuliana Galassi
Journal:  Acta Myol       Date:  2020-09-01

2.  Predictors of respiratory decline in myotonic dystrophy type 1 (DM1): a longitudinal cohort study.

Authors:  Marco Mazzoli; Alessandra Ariatti; Giancarlo Garuti; Virginia Agnoletto; Riccardo Fantini; Alessandro Marchioni; Giuliana Galassi
Journal:  Acta Neurol Belg       Date:  2020-07-10       Impact factor: 2.396

3.  Assessment of Respiratory Function and Need for Noninvasive Ventilation in a Cohort of Patients with Myotonic Dystrophy Type 1 Followed at One Single Expert Center.

Authors:  Carola R Ferrari Aggradi; Elisa Falcier; Andrea Lizio; Alice Pirola; Jacopo Casiraghi; Alice Zanolini; Elena Carraro; Luca Mauro; Fabrizio Rao; Elisabetta Roma; Antonino Iannello; Elisa De Mattia; Andrea Barp; Sara Lupone; Valentina Gatti; Cristina Italiano; Valeria A Sansone
Journal:  Can Respir J       Date:  2022-06-18       Impact factor: 2.130

Review 4.  Predicting the CTG Repeat Size from a Single Spirometry Test Performed at Any Time during the Disease Course of Myotonic Dystrophy Type 1.

Authors:  Kazuto Katsuse; Kenichiro Sato; Nobuyuki Tanaka; Idai Uchida; Tatsushi Toda; Takashi Mikata; Yasufumi Motoyoshi
Journal:  Intern Med       Date:  2022-08-01       Impact factor: 1.282

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.